Shelby Gorman - Concepedia

Concepedia

Author

Shelby Gorman

GlaxoSmithKline (United States)

Also Known As

S.A. Gorman, Shelby A Gorman, Shelby A. Gorman, Shelby Gorman, Shelby A. Gorman

15

Publications

1.2K

Citations

11

H-Index

31

Concepts

All Affiliations

GlaxoSmithKline (United States)Research Triangle Park Foundation Princess Margaret Cancer Centre The Netherlands Cancer Institute Institut Gustave Roussy

SG

About

Shelby Gorman is an author at GlaxoSmithKline (United States) specializing in medicine, radiation oncology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	822
2	Cell Biology	2	2	148
3	Health Sciences	1	1	132
4	Cellular Physiology	1	1	132
5	Immunology	1	1	46

Shelby Gorman

×

11

Publications

1.2K

Citations

11

H-Index

	Year	Citations
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC Helai P. Mohammad, Kimberly N. Smitheman, Chandrashekhar D. Kamat, Cancer Cell Oncogenic AgentMedicineEpigenetic ChangePharmacologyLsd1 Inhibitors	2015	498
Small and intermediate conductance Ca 2+ -activated K + channels confer distinctive patterns of distribution in human tissues and differential cellular localisation in the colon and corpus cavernosum Mao Xiang Chen, Shelby Gorman, Bill Benson, Naunyn-Schmiedeberg s Archives of Pharmacology Differential Cellular LocalisationSignal TransductionNeurophysiologyDistinctive PatternsPhysiology	2004	132
METEOR-1: A phase I study of GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours L.L. Siu, Drew Rasco, S. P. Vinay, Annals of Oncology Molecular BiologyAdvanced Solid TumoursAnti-cancer AgentTumor SuppressorCancer Genetics	2019	130
Gene expression profiling in whole blood identifies distinct biological pathways associated with obesity Sujoy Ghosh, Robert Dent, Mary‐Ellen Harper, BMC Medical Genomics	2010	79
“Z4” Complex Member Fusions in NUT Carcinoma: Implications for a Novel Oncogenic Mechanism Hitoshi Shiota, Janine E. Elya, Artyom A. Alekseyenko, Molecular Cancer Research	2018	66
Distinct skeletal muscle fiber characteristics and gene expression in diet-sensitive versus diet-resistant obesity Martin F. Gerrits, Sujoy Ghosh, Nihan Kavaslar, Journal of Lipid Research	2010	61
First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1) Sophie Postel‐Vinay, Vincent K. Lam, Willeke Ros, Journal for ImmunoTherapy of Cancer	2023	59
Abstract CT150: A first-in-human phase I study of the OX40 agonist GSK3174998 (GSK998) +/- pembrolizumab in patients (Pts) with selected advanced solid tumors (ENGAGE-1) Sophie Postel‐Vinay, Vincent K. Lam, Willeke Ros, Cancer Research Low Pd-l1 ExpressionOx40 Agonist Gsk3174998ImmunologyImmunoeditingPathology	2020	46
Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine Masafumi Ikeda, Tatsuya Ioka, Akira Fukutomi, Cancer Science	2017	45
A Phase I/II Study to Investigate the Safety and Clinical Activity of the Protein Arginine Methyltransferase 5 Inhibitor GSK3326595 in Subjects with Myelodysplastic Syndrome and Acute Myeloid Leukemia Justin M. Watts, Terrence Bradley, Amber Thomassen, Blood	2019	41

Page 1